Antiplatelet and anticoagulant therapy during coronary thrombolysis

This publication has 28 references indexed in Scilit:

• Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.
  Circulation Research, 1989
• Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
  Journal of Clinical Investigation, 1988
• Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
  Circulation, 1988
• Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
  Circulation, 1988
• Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
  Circulation, 1988
• Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay
  Blood, 1988
• Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.
  Journal of Clinical Investigation, 1987
• Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis
  Journal of the American College of Cardiology, 1987
• A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
  Journal of Clinical Investigation, 1985
• The multiple complexes formed by the interaction of platelet factor 4 with heparin
  Biochemical Journal, 1980